Betacellulin drives therapy resistance in glioblastoma

Autor: Shokat, K.M., Baldwin, A., Wong, R.A., Weiss, W.A., Luo, X., Haderk, F., Bivona, T.G., Fan, Q., Mayekar, M.K., An, Z., Lu, E.D.

Background: The transcription factor signal transducer and activator of transcription 3 (STAT3) drives progression in glioblastoma (GBM), suggesting STAT3 as a therapeutic target. Surprisingly however, GBM cells generally show primary resistance to S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::60b63837d5168150617df8bf8405a7d7

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper

Autor: Mateescu, B., Kowal, E., van Balkom, B., Bartel, S., Bhattacharyya, S., Buzá, E., Buck, A., de Candia, P., Chow, F., Das, S., Driedonks, T., Fernández-Messina, L., Haderk, F., Hil, L, A., Jones, J., Van Keuren-Jensen, K., Lai, C., Lässer, C., Liegro, D., I, Lunavat, T., Lorenowicz, M., Maas, S., Mäger, I., Mittelbrunn, M., Momma, S., Mukherjee, K., Nawaz, M., Pegtel, D., Pfaffl, M., Schiffelers, R., Tahara, H., Théry, C., Tosar, J., Wauben, M., Witwer, K., Nolte-'t Hoen, E.

Publikováno v: Journal of Extracellular Vesicles, 6(1), 2001. Co-Action Publishing
Journal of Extracellular Vesicles, Vol 6, Iss 1 (2017)
Mateescu, B, Kowal, E J K, van Balkom, B W M, Bartel, S, Bhattacharyya, S N, Buzás, E I, Buck, A H, de Candia, P, Chow, F W N, Das, S, Driedonks, T A P, Fernández-Messina, L, Haderk, F, Hill, A F, Jones, J C, Van Keuren-Jensen, K R, Lai, C P, Lässer, C, di Liegro, I, Lunavat, T R, Lorenowicz, M J, Maas, S L N, Mäger, I, Mittelbrunn, M, Momma, S, Mukherjee, K, Nawaz, M, Pegtel, D M, Pfaffl, M W, Schiffelers, R M, Tahara, H, Théry, C, Tosar, J P, Wauben, M H M, Witwer, K W & Nolte-'t Hoen, E N M 2017, ' Obstacles and opportunities in the functional analysis of extracellular vesicle RNA-An ISEV position paper ', Journal of Extracellular Vesicles, vol. 6, no. 1, 1286095 . https://doi.org/10.1080/20013078.2017.1286095
Journal of Extracellular Vesicles
Journal of Extracellular Vesicles, 6(1). Taylor and Francis Ltd.
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Mateescu, B, Kowal, E J K, van Balkom, B W M, Bartel, S, Bhattacharyya, S N, Buzás, E I, Buck, A H, de Candia, P, Chow, F W N, Das, S, Driedonks, T A P, Fernández-Messina, L, Haderk, F, Hill, A F, Jones, J C, Van Keuren-Jensen, K R, Lai, C P, Lässer, C, Liegro, I D, Lunavat, T R, Lorenowicz, M J, Maas, S L N, Mäger, I, Mittelbrunn, M, Momma, S, Mukherjee, K, Nawaz, M, Pegtel, D M, Pfaffl, M W, Schiffelers, R M, Tahara, H, Théry, C, Tosar, J P, Wauben, M H M, Witwer, K W & Nolte-'t Hoen, E N M 2017, ' Obstacles and opportunities in the functional analysis of extracellular vesicle RNA-an ISEV position paper ', Journal of Extracellular Vesicles, vol. 6, no. 1, pp. 1286095 . https://doi.org/10.1080/20013078.2017.1286095
Journal of Extracellular Vesicles, 6 (1)

The release of RNA-containing extracellular vesicles (EV) into the extracellular milieu has been demonstrated in a multitude of different in vitro cell systems and in a variety of body fluids. RNA-containing EV are in the limelight for their capacity

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ec623311721eedc81e3ff101fd5308c
https://doi.org/10.1080/20013078.2017.1286095

B01 Active YAP as a Functional Marker of Drug-Tolerant Persister Cells in EGFR-Mutant and ALK Fusion-Positive NSCLC

Autor: Haderk, F., Fernández-Méndez, C., Shah, K.N., Wu, W., Guan, J., Rotow, J., Allegakoen, D., Olivas, V., Bandyopadhyay, S., Kuo, C., Bivona, T.

Publikováno v: In Journal of Thoracic Oncology February 2020 15(2) Supplement:S27-S27

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.